Work

Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs

Year: 2026
Type: article
Abstract: Poor aqueous solubility remains one of the most significant challenges in modern drug development, limiting the oral bioavailability and therapeutic efficacy of many pharmaceutical compounds. A substantial proportion of newly discovered drug molecules fall into Biopharmaceutics Classification System (BCS) Class II and Class IV categories, where dissolution becomes the rate-limiting step for systemic absorption. Conventional formulation approaches such as micronization, salt formation, and solid dispersions have been employed to enhance drug solubility; however, these methods often suffer from limitations including physical instability, recrystallization, limited drug loading, and lack of controlled release. In recent years, nanotechnology-based drug delivery systems have emerged as promising strategies to address these challenges by simultaneously enhancing solubility and enabling sustained drug release. This review discusses the biopharmaceutical challenges associated with poorly water-soluble drugs and highlights the rationale for employing nanotechnology in sustained drug delivery. Various nanocarrier systems including polymeric nanoparticles, lipid-based nanocarriers, polymeric micelles, dendrimers, nanosuspensions, nanosponges, and nanoemulsions are examined with respect to their structural characteristics and drug release behavior. The mechanisms governing sustained release from nanocarriers, such as diffusion-controlled, degradation-controlled, swelling-controlled, and stimuli-responsive processes, are also discussed. Additionally, key formulation design considerations, characterization techniques, and in-vitro and in-vivo evaluation strategies are summarized. Recent advances including smart nanocarriers, targeted nano-delivery, combination therapy, and integration with 3D printing technologies are highlighted. Finally, current challenges related to large-scale manufacturing, stability, regulatory approval, and cost-effectiveness are discussed along with future perspectives for personalized nanomedicine. Overall, nanotechnology-enabled sustained release systems offer a promising platform to improve the solubility, bioavailability, and therapeutic performance of poorly soluble drugs.
Language: English
Open Access status: green
OpenAlex ID: W7164000285
FWCI:
Cites:
Cited by:
Related to: 10